Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTIS Trial: Antiplatelet Therapy Added to rt-PA in Acute Ischemic Stroke
2006-006829-13Phase 3Terminated
- Sponsor
- Nederlandse Hartstichting
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in ischemic stroke (2 arms), sponsored by Nederlandse Hartstichting. Primary endpoint: Poor functional outcome at 3 months. Started Feb 2008; status: terminated.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2006-006829-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006829-13.